Evidence map›Paper›PMID 35034386›Full record

ArticleSkin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)2022

Sonophoresis with ultrasound-responsive liquid-core nuclei for transdermal drug delivery.

Donghee Park, Jongho Won, Gyounjung Lee, Yongheum Lee, Chul-Woo Kim, Jongbum Seo

Abstract read
In one paragraph

Article in Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Low-Frequency Sonophoresis: A Promising Strategy for Enhanced Transdermal Delivery.Advances in pharmacological and pharmaceutical sciences · 2024
    Review
  7. Review
  8. Sonophoresis with ultrasound-responsive liquid-core nuclei for transdermal drug delivery.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Donghee ParkBioInfra Life Science Inc., Cancer Research Institute, Seoul National University College of Medicine, Jongno-Gu, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0002-7633-2787
Jongho WonBioInfra Life Science Inc., Cancer Research Institute, Seoul National University College of Medicine, Jongno-Gu, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0002-5500-3802
Gyounjung LeeBiSang Soft, 405, Medical Industry Techno Tower, Wonju, Gangwon-do, Republic of Korea.ORCID https://orcid.org/0000-0002-7991-7035
Yongheum LeeDepartment of Biomedical Engineering, Yonsei University, Wonju, Gangwon-do, Republic of Korea.ORCID https://orcid.org/0000-0002-1241-525X
Chul-Woo KimBioInfra Life Science Inc., Cancer Research Institute, Seoul National University College of Medicine, Jongno-Gu, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0002-1229-198X
Jongbum SeoDepartment of Biomedical Engineering, Yonsei University, Wonju, Gangwon-do, Republic of Korea.ORCID https://orcid.org/0000-0002-3851-6139

Funding

Korean government 2020R1A2C1008995National Research Foundation of KoreaNuclear Research and Development Program
6 · The paper itself

Abstract

backgroundSonophoresis can increase the delivery efficiency of various drugs into the skin. A recent advance in sonophoresis is the use of ultrasound-responsive liquid-core nuclei (URLN) to increase the probability of cavitation. In this study, we developed a URLN and ultrasound device, and demonstrated its effectiveness through in vitro and clinical tests. MATERIALS AND

methodsThree types of experiments were designed to evaluate the efficiency of sonophoresis with URLN. First, a Franz diffusion cell with cosmetic ingredients was used to analyze quantitatively the amount of drug delivered to the porcine skin. Second, after the application of sonophoresis with URLN, the porcine skin surface was examined using scanning electron microscopy (SEM) to see the changes in morphology. Finally, a clinical test was performed to verify the utility of sonophoresis with URLN.

resultsThe results indicate that sonophoresis with URLN can increase the amount of compound delivered by approximately 11.9-fold over 6 h for niacinamide and by 7.33-fold over 6 h for adenosine. In addition, we observed approximately 20-30 μm sized pores on porcine skin in SEM images. In clinical testing, the application of sonophoresis with cosmetics containing URLN for 3 min improved the efficiency of transdermal drug delivery by 1.9-fold, the depth of absorption by 2.0-fold, and the speed of absorption by 2.0-fold at 30 min after application.

conclusionWe expect that sonophoresis with specialized URLN in transdermal drug delivery could be used widely for various skin-related applications.

Indexed as

SkinSkin AbsorptionAdministration, CutaneousAnimalsDrug Delivery SystemsHumansPharmaceutical PreparationsSwineUltrasonicsUltrasonographyPharmaceutical Preparationscavitation seedclinical testsonocubesonophoresistransdermal drug deliveryultrasound-responsive liquid-core nuclei

Identifiers

PMID35034386
PMCPMC9907662

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.